Create stunning layouts. Right on your iPad.

	See how designer Nicole Jacek helps make GOOD Magazine, well…good, using the new Adobe Comp CC and InDesign CC. And discover how you can create amazing work, too.
	Try it now

Join the conversation

Internet connection and Adobe ID required. Adobe services, like Adobe Creative Cloud, are available only to users 13 and older. Use of services and applications requires agreement to additional terms and the Adobe Privacy Policy. Applications and services may not be available in all countries or languages and may be subject to change or discontinuation without notice. Additional fees or membership charges may apply.

Adobe, the Adobe logo, Creative Cloud, the Creative Cloud logo and InDesign are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries. All other trademarks are the property of their respective owners.

© 2015 Adobe Systems Incorporated. All rights reserved.

This is a marketing email from Adobe Systems Software Ireland Limited, 4-6 Riverwalk, Citywest Business Park, Dublin 24, Ireland. Click here to unsubscribe, or send an unsubscribe request to the address above.

Your privacy is important to us. Please review Adobe's Privacy Policy by clicking here:
www.adobe.com/in/privacy.html.

PLEASE DO NOT REPLY TO THIS MESSAGE. To obtain information on how to contact Adobe, visit the web at www.adobe.com/in/company/contact.html. If you have a privacy-related complaint, send it to privacy@adobe.com.

This email has been sent to dbtech.hp.alert@blogger.com

Comments

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition. In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates. So, why is this approval so important? First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with...

🚫🚫 P2P lenders to stop liquid funds; and other top tech, startup stories this week

Peer-to-peer (P2P) lending platforms have decided to halt one of their most attractive products from March 31 following increased regulatory scrutiny by the Reserve Bank of India, we reported on March 22. Unwrapped Stay on top of the biggest stories shaping tech with our deep dives Good morning Reader, ...

🚨🚨 Draft Digital India Act to open for public consultation soon; concerns raised over impact of the Digital Competition bill

When India's Information Technology Act came into being in October 2000, Facebook was four years away from its inception, the first iPhone wouldn't be launched for the next seven years, and the Nasdaq was experiencing an unprecedented implosion of the dotcom bubble. The internet has changed a lot since. Now, to replace the IT Act of 2000, the government is bringing the Digital India Act, the draft of which will be open for public consultation in the next two weeks. This and more in today's ETtech Morning Dispatch. Morning Dispatch Daily news breaks, exclusives and analysis by ET's most-wired reporters ...

DBTECH

Search This Blog